Mike Boggild

5.8k total citations
41 papers, 1.8k citations indexed

About

Mike Boggild is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Mike Boggild has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 17 papers in Neurology and 7 papers in Rheumatology. Recurrent topics in Mike Boggild's work include Multiple Sclerosis Research Studies (28 papers), Peripheral Neuropathies and Disorders (13 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Mike Boggild is often cited by papers focused on Multiple Sclerosis Research Studies (28 papers), Peripheral Neuropathies and Disorders (13 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Mike Boggild collaborates with scholars based in United Kingdom, Australia and Canada. Mike Boggild's co-authors include Anu Jacob, Liene Elsone, David Shakespeare, Carolyn Young, Kerry Mutch, Jacqueline Palace, Kumar Das, Cris S. Constantinescu, Lauren Krupp and Dean M. Wingerchuk and has published in prestigious journals such as Brain, Neurology and The Lancet Neurology.

In The Last Decade

Mike Boggild

38 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Boggild United Kingdom 17 1.3k 969 394 272 154 41 1.8k
Ali Manouchehrinia Sweden 25 1.6k 1.2× 503 0.5× 355 0.9× 221 0.8× 240 1.6× 73 2.1k
Antonio Scalfari United Kingdom 18 1.7k 1.3× 588 0.6× 478 1.2× 178 0.7× 236 1.5× 46 1.9k
Damiano Paolicelli Italy 23 1.3k 1.0× 422 0.4× 433 1.1× 268 1.0× 234 1.5× 81 1.7k
L. P. Weiner United States 9 1.7k 1.3× 834 0.9× 562 1.4× 496 1.8× 177 1.1× 11 2.1k
L. Truyen Belgium 13 786 0.6× 319 0.3× 345 0.9× 384 1.4× 194 1.3× 18 1.6k
Jonatan Salzer Sweden 21 1.6k 1.2× 638 0.7× 258 0.7× 537 2.0× 201 1.3× 49 2.1k
Gilles Edan France 21 903 0.7× 668 0.7× 318 0.8× 208 0.8× 177 1.1× 66 1.8k
Wallace Brownlee United Kingdom 20 1.1k 0.9× 503 0.5× 232 0.6× 96 0.4× 181 1.2× 66 1.5k
Bruno Musch United States 12 782 0.6× 615 0.6× 171 0.4× 136 0.5× 172 1.1× 29 1.4k
B. Bass Canada 12 1.7k 1.3× 766 0.8× 598 1.5× 222 0.8× 152 1.0× 28 2.1k

Countries citing papers authored by Mike Boggild

Since Specialization
Citations

This map shows the geographic impact of Mike Boggild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Boggild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Boggild more than expected).

Fields of papers citing papers by Mike Boggild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Boggild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Boggild. The network helps show where Mike Boggild may publish in the future.

Co-authorship network of co-authors of Mike Boggild

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Boggild. A scholar is included among the top collaborators of Mike Boggild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Boggild. Mike Boggild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simpson, Steve, Vicki E. Maltby, Sophia Ward, et al.. (2024). Longitudinal epidemiology of multiple sclerosis over 60 years in Newcastle, Australia: 1961 to 2021. Multiple Sclerosis and Related Disorders. 90. 105786–105786. 2 indexed citations
2.
Simpson, Steve, Jeanette C. Reece, Jeannette Lechner‐Scott, et al.. (2023). Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022. Multiple Sclerosis and Related Disorders. 77. 104845–104845. 4 indexed citations
3.
Downing, Jennifer, et al.. (2022). Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis. Multiple Sclerosis and Related Disorders. 59. 103511–103511. 1 indexed citations
4.
Robertson, Thomas, et al.. (2021). Cerebral amyloid angiopathy with related inflammation masquerading as crescendo transient ischaemic attacks. Practical Neurology. 22(3). 216–219. 4 indexed citations
5.
Palace, Jacqueline, Martin Duddy, Michael Lawton, et al.. (2018). Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme. Journal of Neurology Neurosurgery & Psychiatry. 90(3). 251–260. 25 indexed citations
6.
7.
Palace, Jacqueline, Thomas Bregenzer, Helen Tremlett, et al.. (2014). UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model. BMJ Open. 4(1). e004073–e004073. 71 indexed citations
8.
Ellis, Richard, Sean Brown, & Mike Boggild. (2014). Therapy-related acute leukaemia with mitoxantrone: Four years on, what is the risk and can it be limited?. Multiple Sclerosis Journal. 21(5). 642–645. 19 indexed citations
9.
Jacob, Anu, Daniel Lythgoe, Liene Elsone, et al.. (2013). The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom. Journal of Neurology. 260(8). 2134–2137. 69 indexed citations
10.
11.
Sethu, Swaminathan, Meenu Wadhwa, Richard Stebbings, et al.. (2013). Immunoglobulin G1 and immunoglobulin G4 antibodies in multiple sclerosis patients treated with IFNβ interact with the endogenous cytokine and activate complement. Clinical Immunology. 148(2). 177–185. 9 indexed citations
12.
Kitley, Joanna, Maria Isabel Leite, Ichiro Nakashima, et al.. (2012). Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 135(6). 1834–1849. 301 indexed citations
13.
Pfeffer, Gerald, Emma L. Blakely, Charlotte L. Alston, et al.. (2012). Adult-onset spinocerebellar ataxia syndromes due toMTATP6mutations. Journal of Neurology Neurosurgery & Psychiatry. 83(9). 883–886. 37 indexed citations
14.
Singh, Varun Kumar, et al.. (2010). Fasciculations and cramps: how benign? Report of four cases progressing to ALS. Journal of Neurology. 258(4). 573–578. 13 indexed citations
15.
Salminen, Heidi, et al.. (2010). Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. Journal of Neurology. 257(12). 2020–2023. 56 indexed citations
16.
Boggild, Mike. (2009). Immunosuppression followed by immunomodulation. Journal of the Neurological Sciences. 277. S50–S54. 15 indexed citations
17.
Pickin, Mark, Cindy Cooper, Tim Chater, et al.. (2009). The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future. BMC Neurology. 9(1). 1–1. 73 indexed citations
18.
Kumar, Anil, Shery Thomas, Rebecca McLean, et al.. (2009). Treatment of Acquired Periodic Alternating Nystagmus With Memantine. Clinical Neuropharmacology. 32(2). 109–110. 15 indexed citations
19.
20.
Jacob, Anu, et al.. (2004). Charles Bonnet syndrome—elderly people and visual hallucinations. BMJ. 328(7455). 1552–1554. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Manouchehrinia Breakdown of academic impact, for papers by Antonio Scalfari Breakdown of academic impact, for papers by Damiano Paolicelli Breakdown of academic impact, for papers by L. P. Weiner Breakdown of academic impact, for papers by L. Truyen Breakdown of academic impact, for papers by Jonatan Salzer Breakdown of academic impact, for papers by Gilles Edan Breakdown of academic impact, for papers by Wallace Brownlee Breakdown of academic impact, for papers by Bruno Musch Breakdown of academic impact, for papers by B. Bass
Rankless by CCL
2026